Abnormal Properties and Behaviors of Antithrombin III Found in a Thrombophilic Patient: Defective Biological Functions and Dissimilar Antigenic Determinants
- 1 October 1986
- journal article
- research article
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 56 (02) , 165-171
- https://doi.org/10.1055/s-0038-1661633
Abstract
Summary: Abnormal properties of antithrombin III have been found in a 55-year-old male who has been thrombophilic over the last seven years. They are characterized by 1) defective inhibition of thrombin and activated blood coagulation factor X, 2) reduced affinity to heparin and 3) partial immunological identity with the normal molecule. The antithrombin III molecule, however, preserves a single-chain structure and an apparently identical molecular weight with that of the normal molecule. It is, thus, very unlikely that the impaired functions of antithrombin III in the patient’s plasma are induced by possible proteolytic modifications of the molecule by thrombin or other related activated blood coagulation factors.Since no other members of his immediate family have been found to be affected, the abnormality may be acquired rather than genetically determined, although further investigation is necessary for the elucidation of the abnormality of the molecule.Keywords
This publication has 23 references indexed in Scilit:
- Release of a Two‐Chain Form of Antithrombin from the Antithrombin‐Thrombin ComplexEuropean Journal of Biochemistry, 1979
- Routes of Thrombin Action in the Production of Proteolytically Modified, Secondary Forms of Antithrombin‐Thrombin ComplexEuropean Journal of Biochemistry, 1979
- Dissociation of complexes and their derivatives formed during inhibition of bovine thrombin and activated factor X by antithrombin III.Journal of Biological Chemistry, 1979
- The α2-plasmin inhibitor levels in liver diseasesClinica Chimica Acta; International Journal of Clinical Chemistry, 1978
- Severe Antithrombin III Deficiency in an Infant Associated with Multiple Arterial and Venous ThrombosesThrombosis and Haemostasis, 1976
- Antifactor Xa Activity Measured with Amidolytic MethodsPathophysiology of Haemostasis and Thrombosis, 1976
- Quantitative Estimation of Split Products of Fibrinogen in Human Serum, Relation to Diagnosis and TreatmentBlood, 1966
- Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodiesAnalytical Biochemistry, 1966
- The Partial Thromboplastin Time with Kaolin: A Simple Screening Test for First Stage Plasma Clotting Factor DeficienciesAmerican Journal of Clinical Pathology, 1961
- A NEW METHOD FOR THE DETERMINATION OF FIBRINOGEN IN SMALL SAMPLES OF PLASMA1951